| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.16 | 0.4 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |